Renalytix Plc Stock Deutsche Boerse AG
Equities
2O9
GB00BYWL4Y04
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.138 EUR | -14.29% | -33.65% | -26.20% |
Jun. 25 | Shares in Renalytix plunge on possible ADS suspension on Nasdaq | AN |
Jun. 25 | Renalytix to Appeal Nasdaq Delisting Over Non-compliance | MT |
Sales 2024 * | 2.5M 2.34M | Sales 2025 * | 6.98M 6.52M | Capitalization | 24.84M 23.24M |
---|---|---|---|---|---|
Net income 2024 * | -32M -29.93M | Net income 2025 * | -24M -22.45M | EV / Sales 2024 * | 9.93 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.56 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.53% |
Latest transcript on Renalytix Plc
1 day | -14.29% | ||
1 week | -33.65% | ||
Current month | -19.30% | ||
1 month | -36.11% | ||
3 months | -63.30% | ||
6 months | -3.50% | ||
Current year | -26.20% |
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 18-03-14 |
Howard Doran
PSD | President | 63 | 23-08-31 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 18-03-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 21-08-29 |
Chairman | 72 | 18-03-14 | |
James McCullough
FOU | Founder | 56 | 18-03-14 |
Date | Price | Change |
---|---|---|
24-06-26 | 0.138 | -14.29% |
24-06-25 | 0.161 | -14.81% |
Delayed Quote Deutsche Boerse AG, June 26, 2024 at 09:29 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-54.19% | 2.26B | |
+19.59% | 1.89B | |
-8.65% | 1.52B | |
+17.35% | 1.19B | |
-24.23% | 871M | |
+1.25% | 781M | |
-34.22% | 750M | |
-29.46% | 591M | |
+16.98% | 560M |
- Stock Market
- Equities
- RENX Stock
- 2O9 Stock